J. Van Gelder
- Oncology
- Pharmaceutical Science top 5%
- Infectious Diseases top 10%
- Molecular Biology
- Pediatrics, Perinatology and Child Health
- Co-authors
- Patrick AugustijnsErik De ClercqRenaat KingetLieve NaesensS. DefermeGuy Van den MooterPieter AnnaertXuan Ding
- Topics
- HIV/AIDS drug development and treatment (9 papers)Biochemical and Molecular Research (5 papers)Drug Transport and Resistance Mechanisms (4 papers)
- Partner nations
- BelgiumAustraliaNetherlands
In The Last Decade
J. Van Gelder
15 papers receiving 431 citations
Peers
Comparison fields: 5 of 77
- Oncology 144
- Pharmaceutical Science 133
- Infectious Diseases 115
- Molecular Biology 99
- Pediatrics, Perinatology and Child Health 73
Countries citing papers authored by J. Van Gelder
This map shows the geographic impact of J. Van Gelder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Van Gelder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Van Gelder more than expected).
Fields of papers citing papers by J. Van Gelder
This network shows the impact of papers produced by J. Van Gelder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Van Gelder. The network helps show where J. Van Gelder may publish in the future.
Co-authorship network of co-authors of J. Van Gelder
This figure shows the co-authorship network connecting the top 25 collaborators of J. Van Gelder. A scholar is included among the top collaborators of J. Van Gelder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Van Gelder. J. Van Gelder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 38 | |
| 3 | 47 | |
| 4 | 81 | |
| 5 | 21 | |
| 6 | 35 | |
| 7 | 52 | |
| 8 | 30 | |
| 9 | Oral absorption characteristics of the antiviral agent UC-781 | 1 |
| 10 | 36 | |
| 11 | Increased oral absorption of the antiviral ester prodrug Tenofovir disoproxil in rat ileum | 3 |
| 12 | 25 | |
| 13 | 18 | |
| 14 | 17 | |
| 15 | 17 |
About J. Van Gelder
J. Van Gelder is a scholar working on Infectious Diseases, Physiology and Virology, having authored 15 papers that have together received 444 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), Biochemical and Molecular Research (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Pharmaceutical Science (133 citations), Virology (58 citations) and Infectious Diseases (115 citations). J. Van Gelder has collaborated with scholars based in Belgium, Australia and Netherlands. Frequent co-authors include Patrick Augustijns, Erik De Clercq, Renaat Kinget, Lieve Naesens, S. Deferme, Guy Van den Mooter, Guy Van den Mooter, Pieter Annaert, Xuan Ding and John P. Rose. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.